The Drug Enforcement Administration (DEA) published its formal proposal for cannabis rescheduling, officially putting what is set to be the most meaningful overhaul of cannabis regulation in 50-years into motion.
Tuesday’s (May 21, 2024) publication of the proposal means that the 60-day comment period is now open, giving commenters until July 22 to submit their comments electronically. Interested parties may also file a request for a hearing on or before June 20.
In its proposal, the DEA says that the Attorney General has determined that cannabis does not appear to meet the elements of a Schedule II drug, including high potential for abuse and the likelihood of severe physiological or physical dependence.
It also notes that synthetically produced cannabis would not be included in the reclassification, which is outside of the Controlled Substances Act’s (CSA) definition, and will therefore remain a Schedule I substance.
Comments are now being sought from ‘all interested persons’, and are expected to include the general public, stakeholders in the medical and scientific community, legal and regulatory experts, industry representatives, advocacy groups, and government agencies.
Specifically, the proposal calls for comments relating to the economic analysis of the proposed changes and encourages commenters to provide detailed descriptions, especially concerning the impact on small entities, and to support their comments with empirical data.
In this vein, the DOJ says it ‘acknowledges that there may be large impacts related to Federal taxes and research and development investment for the pharmaceutical industry, among other things.’
Furthermore, it states that the Attorney General, Merick Garland, must consider compliance with international treaty obligations, including the Single Convention, which requires signatories to ‘maintain various provisions related to the drugs’ covered by the treaty.
While no prospective timeline was given for how long the comments will take to consider, or whether a final hearing will take place, sources speaking to Business of Cannabis have suggested the change could be finalised by Q1 2025.
DEA & DOJ Officially Submit Proposal for Cannabis Rescheduling, Setting Comment Period in Motion
The Drug Enforcement Administration (DEA) published its formal proposal for cannabis rescheduling, officially putting what is set to be the most meaningful overhaul of cannabis regulation in 50-years into motion.
Tuesday’s (May 21, 2024) publication of the proposal means that the 60-day comment period is now open, giving commenters until July 22 to submit their comments electronically. Interested parties may also file a request for a hearing on or before June 20.
In its proposal, the DEA says that the Attorney General has determined that cannabis does not appear to meet the elements of a Schedule II drug, including high potential for abuse and the likelihood of severe physiological or physical dependence.
It also notes that synthetically produced cannabis would not be included in the reclassification, which is outside of the Controlled Substances Act’s (CSA) definition, and will therefore remain a Schedule I substance.
Comments are now being sought from ‘all interested persons’, and are expected to include the general public, stakeholders in the medical and scientific community, legal and regulatory experts, industry representatives, advocacy groups, and government agencies.
Specifically, the proposal calls for comments relating to the economic analysis of the proposed changes and encourages commenters to provide detailed descriptions, especially concerning the impact on small entities, and to support their comments with empirical data.
In this vein, the DOJ says it ‘acknowledges that there may be large impacts related to Federal taxes and research and development investment for the pharmaceutical industry, among other things.’
Furthermore, it states that the Attorney General, Merick Garland, must consider compliance with international treaty obligations, including the Single Convention, which requires signatories to ‘maintain various provisions related to the drugs’ covered by the treaty.
While no prospective timeline was given for how long the comments will take to consider, or whether a final hearing will take place, sources speaking to Business of Cannabis have suggested the change could be finalised by Q1 2025.
Could Rescheduling Finally Bring Institutional Investment in to Cannabis?
Next PostAkanda Implements 2nd Stock Split Amid Debt Woes, DanCann Pharma Earnings Fall Due to Strategy Change, & More From Celadon
Ben Stevens
Editor and Journalist with more than seven years experience reporting on business and financial sectors.
Related Posts
Related Posts
North Carolina Senate Passes Medical Cannabis Legalization Bill
North Carolina’s Senate has approved legislation aiming to legalize medical cannabis, putting the state a step closer to becoming the...
Anti-Cannabis Group Calls on DOJ to Extend Rescheduling Comment Period to Collect More Data
A prohibitionist group, represented by Torridon Law PLLC, founded by former Attorney General William Barr, is urging the DEA to...
‘Hemp Killing’ Amendment Would Not Ban All Hemp Cannabinoids, Says Leading Think Tank
The Cannabist Company Plans to Exit Florida Entirely Amid $10m Cost Saving Initiative
‘Door is Now Open’ For Cannabis Companies on the Isle of Man as it Seeks to Home 10 Businesses This Year
Trulieve Agrees to $350,000 Fine Over 2022 Worker’s Death
CONNECT
Related Posts
Related Posts
North Carolina Senate Passes Medical Cannabis Legalization Bill
North Carolina’s Senate has approved legislation aiming to legalize medical cannabis, putting the state a step closer to becoming the...
Anti-Cannabis Group Calls on DOJ to Extend Rescheduling Comment Period to Collect More Data
A prohibitionist group, represented by Torridon Law PLLC, founded by former Attorney General William Barr, is urging the DEA to...
‘Hemp Killing’ Amendment Would Not Ban All Hemp Cannabinoids, Says Leading Think Tank
The US Congressional Research Service (CRS) this week published a report on proposed amendments to the US Farm Bill, which...
The Cannabist Company Plans to Exit Florida Entirely Amid $10m Cost Saving Initiative
The Cannabist Company, formerly Columbia Care, has announced a string of cost cutting measures that will make the company ‘look...
‘Door is Now Open’ For Cannabis Companies on the Isle of Man as it Seeks to Home 10 Businesses This Year
The Isle of Man, a UK crown dependency, has been clear about its intention to welcome medical cannabis businesses, announcing...
Recent Posts
Related Posts
Anti-Cannabis Group Calls on DOJ to Extend Rescheduling Comment Period to Collect More Data
A prohibitionist group, represented by Torridon Law PLLC, founded by former Attorney General William Barr, is urging the DEA to...
South Dakota to Vote on Cannabis Legalization for 3rd Time
Adult-use cannabis legalization is set to go to the ballot box for the third time in South Dakota this November....
Cannabis Regulation and THC Driving Limits Under Scrutiny in Bundestag Hearings
On Monday, 4th June 2024, two expert hearings were held regarding the laws ‘to amend the Cannabis Consumption Act and...
South Africa Decriminalises Cannabis Ahead of Historic Election
On the eve of a historic election, the incumbent South African President, Cyril Ramaphosa, officially signed a long-awaited cannabis decriminalisation...
Cannabis Rescheduling Tensions Rise as DEA’s Milgram Faces Scrutiny From GOP
The Drug Enforcement Agency’s (DEA) Administrator, Anne Milgram, has come under fire from GOP congressmen over the apparent divergence of...
Subscribe to our mailing list to receives daily updates!
We won’t spam you
Categories
Browse by Tags